Cadiz Engages MZ Group To Enhance Strategic Investor Relations Program

Company's Critical Inflection Point Under Susan Kennedy's New Leadership Drives Expansion of Investor CommunicationsRecent Form 4 Filing Disclosed CEO's Purchase of Shares of CDZI to Align with ShareholdersLOS ANGELES,

Company’s Critical Inflection Point Under Susan Kennedy’s New Leadership Drives Expansion of Investor Communications

Recent Form 4 Filing Disclosed CEO’s Purchase of Shares of CDZI to Align with Shareholders

LOS ANGELES, May 9, 2024 /PRNewswire/ — Cadiz, Inc. (NASDAQ:CDZI, CDZIP))))) (“Cadiz” or the “Company”), a California water solutions company, has engaged international investor relations specialists MZ Group (“MZ”) to lead a comprehensive strategic investor relations and financial communications program across all key markets at a pivotal inflection point for the Company. Several key developments over the last six months demonstrate this inflection point including critical permitting and contracting milestones in the development of water and infrastructure assets.

MZ Group will work closely with Cadiz management to develop and implement a capital markets strategy designed to increase the Company’s visibility throughout the investment community.

Total
0
Shares
Related Posts
Read More

89bio Data Showed Pegozafermin Treatment Was Found To Be Effective In Reducing Triglycerides And Other Atherogenic Lipids In Patients With SHTG, Regardless Of Their Background Lipid-modifying Therapy

89bio, Inc. (Nasdaq: ETNB) today announced the presentation of additional data from the Phase 2 ENTRIGUE trial of pegozafermin in patients with severe hypertriglyceridemia (SHTG) at the American College of Cardiology's 72nd Annual Scientific Session & Expo Together with World Congress of Cardiology (ACC.23/WCC).

ETNB